Skip to content

The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis.

Meta-analysis · Int J Geriatr Psychiatry · 2016. Source record refreshed; an explanation has not been reviewed.

Meta-analysisSource: PubMed · PMID 26680338

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis.

Kobayashi H, Ohnishi T, Nakagawa R et al.
Int J Geriatr Psychiatry · 2016

PubMed ID
26680338
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.